Dr. Samuel Klein from the Washington University School of Medicine is researching a new GLP 3 weight-loss drug. He says his clinical trials are looking to recruit women who would like to be part of the trials that also include exercise classes. He warns that some Americans are getting the popular weight-loss drugs through the 'gray market' with no medical supervision.
For more information on the clinical trials he's leading -- 314-273-1879 nutritionresearch@wustl.edu

Apr 09, 2026





